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Genoa Syndrome and Central Diabetes 




Genoa syndrome was first described by Camera et al in
1993 (1). They reported two patients with semilobar holop-
rosencephaly (HPE), craniosynostosis involving the coronal
and lambdoid sutures and abnormal small hands with 
cone-shaped epiphyses and hypoplastic terminal phalanges
of fingers. The authors named this possibly autosomal 
recessive disorder "Genoa syndrome," after the name of the
city where both cases were described. In 2001, Lapunzina
et al (2) reported a case of craniosynostosis and HPE 
associated with several other malformations such as 
cloverleaf skull, Dandy-Walker malformation, bilateral 
microphthalmia, cleft soft palate, congenital scoliosis. They
concluded that these findings could be attributed to a 
severe form of Genoa syndrome or to a newly recognized
syndrome.
HPE is the most common developmental defect of the
forebrain and mid-face in humans and occurs in 5-12/10000
live births. Clinically, there is a continuous spectrum of 
malformations consistent with HPE. Endocrinopathies, such
as diabetes insipidus, hypothyroidism, hypocorticism, and
growth hormone deficiency, are frequently associated with
HPE (3). 
We report a case of semilobar HPE, craniosynostosis
and cleft lip/palate, considered to be a case of Genoa
syndrome, which was associated with central diabetes 
insipidus. 
ABSTRACT
Genoa syndrome was first described by Camera et al in 1993 in two
patients with semilobar holoprosencephaly (HPE), craniosynostosis and
abnormal small hands with cone-shaped epiphyses and hypoplastic 
terminal phalanges of fingers (OMIM: 601370). In 2001, Lapunzina et al
reported a case of craniosynostosis and HPE associated with several
other malformations and suggested that these findings could be 
attributed to a severe form of Genoa syndrome or to a newly recognized
syndrome. Endocrinopathies in association with HPE are frequently
reported in the literature. Diabetes insipidus, hypothyroidism, 
hypocortisolism, and growth hormone deficiency are frequently associated
with HPE. We here report a case of semilobar HPE, craniosynostosis and
cleft lip/palate, possibly a case of Genoa syndrome, associated with 
central diabetes insipidus. 
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A 12-month-old boy was admitted to our department
with hypernatremia. He was born after 40 weeks of 
gestation as the first child of a first cousin consanguineous
couple. There was no family history of congenital defects;
the pregnancy was uneventful. Brain magnetic resonance
was performed and showed semilobar HPE (Figure 1). The
patient was operated for craniosynostosis when he was 8
months old. Fifteen days after the surgery he had seizures,
was diagnosed as having West syndrome and started on 
vigabatrine therapy. His cleft palate was surgically 
reconstructed at the age of 11 months. The patient did not
have any seizures after 10 months of age. During his
follow-up, hypernatremia was noted. He was diagnosed
with diabetes insipidus and received desmopressin acetate
(dDAVP) therapy. He was referred to our department atfer
a hospitalization for pneumonia . At presentation, he had 
been off dDAVP for ten days. 
On admission, he had microcephaly (40.5 cm <3rd
percentile), bilateral cleft lip, a flat nose (Figure 2). His body
weight was 6.6 kg (<3rd percentile) and height was 67 cm
(10th percentile). There were no clinical signs of dehydration
in spite of severe hypernatremia (Na: 161 mEq/L). Serum
and urine osmolarity were 337 and 157 mOsm/kg, 
respectively (urine osmolarity/serum osmolarity ratio: 0.46).
Urine specific gravity was 1005; urine sodium was 61
mmol/L. He had polyuria (5.9 mL/kg/h). Serum antidiuretic
hormone (ADH) level was 0.7 pmol/L (N:2-8 pmol/L). We 
re-started dDAVP therapy (2x2.5.μ/bid). Pituitary gland MRI
showed absence of normal hyperintensity of neurohypophysis
(Figure 3). After dDAVP therapy, serum sodium level 
decreased to 148 mmol/L, serum osmolarity was 
normalized (289 mosm/kg/H20) and urine osmolarity was 300
mosm/kg/H20 (urine osmolarity/serum osmolarity ratio: 1.03).
His karyotype was normal.
The patient had no clinical or laboratory signs of other 
pituitary hormone deficiencies. He responded very well to
vasopressin treatment with restoration of serum electrolytes,
which remained within normal limits at the 6-month 
follow-up. Clinical response to vasopressin confirmed the
diagnosis of central diabetes insipidus.
Discussion
Syndromes with craniosynostosis have been extensively
reviewed elsewhere by Cohen and MacLean (4). To date,
there are more than 100 disorders with craniosynostosis as
a manifestation. In 1993, Camera et al reported an unusual
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Figure 1. Semilobar HLP  Figure 3. Absence of normal neurohypophysial hyperintensity
Figure 2. Microcephaly, bilateral cleft lip and flat nosetype of craniosynostosis associated with HPE and several
skeletal anomalies in two sibs. This rare type of 
craniosynostosis was named as Genoa syndrome. In addition
to semilobar HPE and craniosynostosis, this case also had
craniofacial asymmetry, hydrocephalus, brachycephaly, 
plagiocephaly, hypotonia, ocular hypotelorism, clinodactyly,
hypoplastic terminal phalanx, cone-shaped epiphyses, small
vertebral bodies, and slender long bones (1). Lapunzina et al
(2) reported a case of craniosynostosis and HPE associated
with several other malformations such as cloverleaf skull,
Dandy-Walker malformation, bilateral microphthalmia, cleft
soft palate, congenital scoliosis, aortic coarctation with 
patent ductus arteriosus. They concluded that these 
findings could be attributed to a severe form of Genoa
syndrome or to a newly recognized syndrome. Our case
had semilobar HPE, bilateral coronal and metopic 
craniosynostosis, microcephaly, epicanthal fold, flat nose,
hypotonia, bilateral cleft lip/palate and growth delay. 
Contrary to the cases previously described, our patient did
not show upslanting palpebral fissures, pigmented retinal
degeneration, small hands nor other skeletal anomalies. 
Also our patients did not have a cardiac anomaly. We 
evaluated our patient as Genoa syndrome because of 
semilobar HPE and craniosynostosis, two findings being
the main features in patients diagnosed with Genoa 
syndrome in previous reports. 
Because only three cases with Genoa syndrome have 
been reported so far, additional cases are needed to clarify the
several features of this unusual syndromic craniosynostosis
and HPE. 
HPE is a condition in which the early forebrain does not
undergo diverticulation and instead of it develops into a
single, unpaired forebrain, the so-called holoprosencephalon.
It can be lobar, semilobar, variant, or alobar (with a large 
holoventricle). In the semilobar HPE, the facial anomalies
are mild or absent (5). Seizures are often present. 
Yoshikawa et al (6) reported the case of a child with West
syndrome associated with semilobar HPE. Our patient was
also diagnosed as having West syndrome, when he was 8
months old. 
Endocrinopathies in association with HPE are frequently
reported in the literature. Children with HPE are at risk for
hypothalamic and pituitary dysfunction because of midline
defects. In a review of 117 children with HPE, Hahn et al (7)
identified hypothyrodism in 11%, hypocortisolism in 7%,
and growth hormone deficiency in 5% of patients; diabetes
insipidus occurred in 70% of patients with classic HPE. This
is not surprising, because the hypothalamus is located 
medially and rostrally in the early fetal maps and therefore
is more frequently noncleaved than structures located 
farther from the midline or more caudally.
Posterior pituitary dysfunctions are more common than
anterior ones. Due to the abnormal hypothalamic–infundibular
region in HPE, a defect in the supraoptic and paraventricular
nuclei of the hypothalamus or in the release of vasopressin
via the infundibulum and posterior pituitary can lead to 
diabetes insipidus. Some authors have attributed the 
occurrence of diabetes insipidus to abnormal hypothalamic
osmoreceptors as normal posterior pituitary is often 
visualized on MRI, while others hypothesized that the 
genes involved in the cerebral malformation have 
secondary genetic effects on the development of the
hypothalamic neurons (5). Diabetes insipidus can even be
recognized in infancy in patients with HPE (8). Based on the
absence of normal neurohypophysis hyperintensity, we 
believe that diabetes insipidus in our patient was due to an
anatomical defect. 
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